Teladoc Health Reports Second Quarter 2024 Results

Go back to Teladoc Health Reports Second Quarter 2024 Results

Teladoc (TDOC) PT Lowered to $10 at Deutsche Bank

August 1, 2024 4:00 PM EDT

Deutsche Bank analyst George Hill lowered the price target on Teladoc (NYSE: TDOC) to $10.00 (from $15.00) while maintaining a Hold rating.

The analyst comments "TDOC Provides Half-a-Guidance as BetterHelp Struggles: TDOC reported Q2 results where the company pulled its 2024 and long term... More

Teladoc (TDOC) PT Lowered to $9 at RBC Capital

August 1, 2024 6:32 AM EDT

RBC Capital analyst Sean Dodge lowered the price target on Teladoc (NYSE: TDOC) to $9.00 (from $18.00) while maintaining a Outperform rating.

The analyst comments "Q2 was challenging for TDOC. Revenue missed consensus by 1.1% and while EBITDA came in 20.4% ahead, much of the upside was... More